Evidence map›Paper›PMID 28976958›Full record

ArticleNature2017

TORC1 organized in inhibited domains (TOROIDs) regulate TORC1 activity.

Manoël Prouteau, Ambroise Desfosses, Christian Sieben, Clélia Bourgoint, Nour Lydia Mozaffari, Davide Demurtas, Alok K Mitra, Paul Guichard, Suliana Manley, Robbie Loewith

Open access · greenAbstract read
In one paragraph

Article in Nature, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Quiescence inAnnual review of genetics · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Manoël ProuteauDepartment of Molecular Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, Switzerland.
Ambroise DesfossesSchool of Biological Sciences, University of Auckland, Private Bag 92019, Auckland 1010, New Zealand.
Christian SiebenInstitute of Physics, Laboratory of Experimental Biophysics, École Polytechnique Fédérale de Lausanne (EPFL), CH1015 Lausanne, Switzerland.
Clélia BourgointDepartment of Molecular Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, Switzerland.
Nour Lydia MozaffariDepartment of Molecular Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, Switzerland.
Davide DemurtasInterdisciplinary Centre for Electron Microscopy, École Polytechnique Fédérale de Lausanne (EPFL), CH1015 Lausanne, Switzerland.
Alok K MitraSchool of Biological Sciences, University of Auckland, Private Bag 92019, Auckland 1010, New Zealand.
Paul GuichardDepartment of Cell Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, Switzerland.
Suliana ManleyInstitute of Physics, Laboratory of Experimental Biophysics, École Polytechnique Fédérale de Lausanne (EPFL), CH1015 Lausanne, Switzerland.
Robbie LoewithDepartment of Molecular Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, Switzerland.
University of Geneva · CHÉcole Polytechnique Fédérale de Lausanne · CHUniversity of Auckland · NZ

Funding

European Research Council 243016European Research Council 614552
6 · The paper itself

Abstract

The target of rapamycin (TOR) is a eukaryotic serine/threonine protein kinase that functions in two distinct complexes, TORC1 and TORC2, to regulate growth and metabolism. GTPases, responding to signals generated by abiotic stressors, nutrients, and, in metazoans, growth factors, play an important but poorly understood role in TORC1 regulation. Here we report that, in budding yeast, glucose withdrawal (which leads to an acute loss of TORC1 kinase activity) triggers a similarly rapid Rag GTPase-dependent redistribution of TORC1 from being semi-uniform around the vacuolar membrane to a single, vacuole-associated cylindrical structure visible by super-resolution optical microscopy. Three-dimensional reconstructions of cryo-electron micrograph images of these purified cylinders demonstrate that TORC1 oligomerizes into a higher-level hollow helical assembly, which we name a TOROID (TORC1 organized in inhibited domain). Fitting of the recently described mammalian TORC1 structure into our helical map reveals that oligomerization leads to steric occlusion of the active site. Guided by the implications from our reconstruction, we present a TOR1 allele that prevents both TOROID formation and TORC1 inactivation in response to glucose withdrawal, demonstrating that oligomerization is necessary for TORC1 inactivation. Our results reveal a novel mechanism by which Rag GTPases regulate TORC1 activity and suggest that the reversible assembly and/or disassembly of higher-level structures may be an underappreciated mechanism for the regulation of protein kinases.

Indexed as

Cryoelectron MicroscopyAllelesCatalytic DomainEnzyme ActivationGlucoseMechanistic Target of Rapamycin Complex 1Monomeric GTP-Binding ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsGlucoseGtr1 protein, S cerevisiaeGTR2 protein, S cerevisiaeMechanistic Target of Rapamycin Complex 1Monomeric GTP-Binding ProteinsSaccharomyces cerevisiae Proteins

Identifiers

PMID28976958
PMCPMC5640987
OpenAlexW2763844770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.